BofA has reinstated coverage of 11 large-cap pharmaceutical and biotech stocks, with Eli Lilly (NYSE:LLY), Gilead ...
A Boulder-based company that is developing a orally-delivered drug for obesity and metabolic disorders just reached $25M in ...
The company also raised its quarterly dividend 15% amid rapid growth fueled in part by the blockbuster weight-loss drug ...
Amgen says it will now phase out supply of the original list price national drug codes (NDCs ... BioAge to discontinue its phase 2 trial of obesity candidate azelaprag, hitting the Nasdaq ...
Dow Jones fell in the stock market today. Nvidia rose from a key level of support. AI stock fell after earnings. Tesla got a ...
Garmin stock, along with Ollie's Bargain Outlet, are among the best stocks to watch on the stock market today.
This can be explained by the first generation weight loss product that Novo Nordisk had launched, Saxenda (liraglutide), which had been approved by the FDA to treat obesity in 2014. The product ...
U.S. Marketscategory Wall St indexes fall with inflation data and rates in focus December 10, 2024 U.S. Marketscategory Wall Street closes down as tech stocks fall December 9, 2024 U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback